Symmetry Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-3,566
| Closed | -$1.14M | – | 485 |
|
2024
Q2 | $1.14M | Hold |
3,566
| – | – | 0.06% | 143 |
|
2024
Q1 | $819K | Sell |
3,566
-33
| -0.9% | -$7.58K | 0.06% | 210 |
|
2023
Q4 | $789K | Sell |
3,599
-23
| -0.6% | -$5.04K | 0.04% | 202 |
|
2023
Q3 | $818K | Hold |
3,622
| – | – | 0.04% | 204 |
|
2023
Q2 | $800K | Hold |
3,622
| – | – | 0.04% | 223 |
|
2023
Q1 | $811K | Hold |
3,622
| – | – | 0.04% | 213 |
|
2022
Q4 | $1.01M | Buy |
3,622
+100
| +3% | +$27.8K | 0.06% | 183 |
|
2022
Q3 | $737K | Buy |
3,522
+555
| +19% | +$116K | 0.05% | 221 |
|
2022
Q2 | $699K | Buy |
2,967
+160
| +6% | +$37.7K | 0.05% | 236 |
|
2022
Q1 | $504K | Hold |
2,807
| – | – | 0.03% | 359 |
|
2021
Q4 | $607K | Hold |
2,807
| – | – | 0.04% | 333 |
|
2021
Q3 | $530K | Sell |
2,807
-94
| -3% | -$17.7K | 0.03% | 393 |
|
2021
Q2 | $520K | Hold |
2,901
| – | – | 0.03% | 411 |
|
2021
Q1 | $485K | Hold |
2,901
| – | – | 0.03% | 410 |
|
2020
Q4 | $440K | Buy |
2,901
+353
| +14% | +$53.5K | 0.03% | 410 |
|
2020
Q3 | $257K | Buy |
2,548
+97
| +4% | +$9.78K | 0.02% | 525 |
|
2020
Q2 | $297K | Buy |
+2,451
| New | +$297K | 0.04% | 235 |
|